Inventor · disambiguated record
Tim Beaumont
Also filed as: BEAUMONT TIM
29 granted patents·9 pending applications·188 citations·filing 2006–2024
96Inventor score
Top patents by PatentIndex Score
38 records- 0197US8568726B2RSV specific binding moleculeBEAUMONT TIM·Filed 2010·Granted Oct 29, 2013·62 cites·9 claims
- 0295US10035843B2RSV-specific binding moleculeMEDIMMUNE LTD·Filed 2016·Granted Jul 31, 2018·10 cites·20 claims
- 0395US8562996B2RSV-specific binding molecules and means for producing themSPITS HERGEN·Filed 2008·Granted Oct 22, 2013·33 cites·18 claims
- 0493US9283274B2RSV specific binding moleculeMEDIMMUNE LTD·Filed 2013·Granted Mar 15, 2016·9 cites·34 claims
- 0591US10059757B2RSV-specific binding molecules and means for producing themMEDIMMUNE LTD·Filed 2016·Granted Aug 28, 2018·8 cites·32 claims
- 0690US10730931B2RSV-specific binding molecules and means for producing themMEDIMMUNE LTD·Filed 2018·Granted Aug 4, 2020·3 cites·34 claims
- 0790US8617556B2Gram-positive bacteria specific binding compoundsBEAUMONT TIM·Filed 2011·Granted Dec 31, 2013·12 cites·74 claims
- 0889US10723786B2RSV-specific binding moleculeMEDIMMUNE LTD·Filed 2018·Granted Jul 28, 2020·3 cites·19 claims
- 0988US9399673B2Gram-positive bacteria specific binding compoundsGENENTECH INC·Filed 2013·Granted Jul 26, 2016·7 cites·17 claims
- 1088US9321831B2RSV-specific binding molecules and means for producing themMEDIMMUNE LTD·Filed 2013·Granted Apr 26, 2016·8 cites·23 claims
- 1187US9206247B2Means and methods for producing high affinity antibodiesBEAUMONT TIM·Filed 2011·Granted Dec 8, 2015·7 cites·18 claims
- 1287US9127251B2Means and methods for influencing the stability of antibody producing cellsSPITS HERGEN·Filed 2006·Granted Sep 8, 2015·10 cites·20 claims
- 1387US9090677B2Gram-positive bacteria specific binding compoundsGENENTECH INC·Filed 2013·Granted Jul 28, 2015·6 cites·35 claims
- 1484US9458228B2Gram-positive bacteria specific binding compoundsGENENTECH INC·Filed 2015·Granted Oct 4, 2016·3 cites·46 claims
- 1582US9266943B2Gram-positive bacteria specific binding compoundsGENENTECH INC·Filed 2013·Granted Feb 23, 2016·3 cites·58 claims
- 1678US9273118B2Means and methods for producing high affinity antibodiesBEAUMONT TIM·Filed 2010·Granted Mar 1, 2016·2 cites·7 claims
- 1778US2024425566A1Ex vivo antibody productionKLING BIOTHERAPEUTICS B V·Filed 2024·Application pending·0 cites
- 1874US9718874B2Influenza A virus specific antibodiesSPITS HERGEN·Filed 2012·Granted Aug 1, 2017·2 cites·9 claims
- 1973US2023242667A1Means and methods for counteracting myeloproliferative or lymphoproliferative disordersKLING BIOTHERAPEUTICS B V·Filed 2023·Application pending·0 cites
- 2071US2020325213A1Rsv-specific binding molecules and means for producing themMEDIMMUNE LTD·Filed 2020·Application pending·0 cites
- 2171US2021277094A9Rsv-specific binding moleculeMEDIMMUNE LTD·Filed 2020·Application pending·0 cites
- 2267US12084681B2Ex vivo antibody productionKLING BIOTHERAPEUTICS B V·Filed 2019·Granted Sep 10, 2024·0 cites·19 claims
- 2366US2018292391A1Gram-positive bacteria specific binding compoundsGENENTECH INC·Filed 2018·Application pending·0 cites
- 2464US11629200B2Means and methods for counteracting myeloproliferative or lymphoproliferative disordersKLING BIOTHERAPEUTICS B V·Filed 2020·Granted Apr 18, 2023·0 cites·16 claims
- 2564US2017009205A1Ex vivo antibody productionAIMM THERAPEUTICS BV·Filed 2014·Application pending·0 cites
- 2663US9927428B2Gram-positive bacteria specific binding compoundsGENENTECH INC·Filed 2016·Granted Mar 27, 2018·0 cites·66 claims
- 2762US10273454B2Means and methods for influencing the stability of antibody producing cellsACADEMISCH MEDISCH CENTRUM BIJ DE UNIV VAN AMSTERDAM·Filed 2017·Granted Apr 30, 2019·0 cites·6 claims
- 2862US10017562B2RSV G protein specific antibodiesAIMM THERAPEUTICS BV·Filed 2017·Granted Jul 10, 2018·0 cites·17 claims
- 2962US9688745B2Gram-positive bacteria specific binding compoundsGENENTECH INC·Filed 2015·Granted Jun 27, 2017·0 cites·39 claims
- 3058US9822339B2Means and methods for influencing the stability of antibody producing cellsACADEMISCH MEDISCH CENTRUM BIJ DE UNIV VAN AMSTERDAM·Filed 2015·Granted Nov 21, 2017·0 cites·10 claims
- 3157US10556963B2Means and methods for counteracting myeloproliferative or lymphoproliferative disordersAIMM THERAPEUTICS BV·Filed 2014·Granted Feb 11, 2020·0 cites·16 claims
- 3257US9718876B2RSV G protein specific antibodiesAIMM THERAPEUTICS BV·Filed 2012·Granted Aug 1, 2017·0 cites·1 claims
- 3356US2011020323A1Gram-positive bacteria specific binding compoundsBEAUMONT TIM·Filed 2010·Application pending·0 cites
- 3455US10344076B2Means and methods for producing high affinity antibodiesAIMM THERAPEUTICS BV·Filed 2016·Granted Jul 9, 2019·0 cites·9 claims
- 3550US9969795B2Means and methods for producing high affinity antibodiesAIMM THERAPEUTICS BV·Filed 2015·Granted May 15, 2018·0 cites·8 claims
- 3650US2024317880A1Epithelial Cadherin-Specific AntibodiesKLING BIOTHERAPEUTICS B V·Filed 2021·Application pending·0 cites
- 3743US2017313766A1Influenza a virus specific antibodiesAIMM THERAPEUTICS BV·Filed 2017·Application pending·0 cites
- 3829US10435463B2Hepatitis C virus specific antibodyAIMM THERAPEUTICS BV·Filed 2015·Granted Oct 8, 2019·0 cites·7 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →